Podcasts about promising

Are you on a mission to find the best productivity app or system, and find that no matter how many apps or new methods you try, you still find yourself overwhelmed, backlogged and stuck? Well, this week I want to tell you about a new way I can help you.  Links: Email Me | Twitter | Facebook | Website | Linkedin   Learn more about the Productivity Academy The Working With… Weekly Newsletter Carl Pullein Learning Centre Carl's YouTube Channel Carl Pullein Coaching Programmes Subscribe to my Substack  The Working With… Podcast Previous episodes page Script |427 Hello, and welcome to episode 427 of the Your Time, Your Way Podcast. A podcast to answer all your questions about productivity, time management, self-development, and goal planning. My name is Carl Pullein, and I am your host of this show.  Eleven years ago, I began writing blog posts on time management and productivity. My goal was simple. To help people navigate the rapidly changing world of time management and productivity.  In 2015, it seemed almost every day a new task manager or notes app would come out promising to make organising your day easier.  This meant established productivity apps such as OmniFocus, Things, Remember the Milk and Todoist had to change to keep up. So these apps started adding features, changing their design languages, and everything started to become more complicated. AI today is doing exactly the same thing. Promising a lot and forcing established productivity tools to add more and more features, whether we want them or not.  When trying to decide if a new productivity tool is all that it promises to be, I've noticed that many of these promises are repackaged things that already exist.  For example, I've been using an app called TextExpander for fifteen years now. TextExpander inserts pre-written “snippets” of text through a keyboard shortcut.  I use it for writing dates so I don't need to look up the date. All I type is “Edate”, and it will give me the date in the UK format: day, month and year.  I also have some pre-written thank you emails there too. They are written by me in my writing style, and a simple keyboard shortcut will give me the email. While TextExpander won't send the email for me, all I need to do is hit Command and return on my keyboard, and it will send it.  Then we have tools such as Calendly and Acuity. These tools allow you to set up times on your calendar that people can pick from to set up an appointment with you. Once set up, this works in the background, and you have nothing to do.  No back-and-forth negotiating a time. People just click on a link, and these tools deal with time zone differences and all the admin.  No need for AI to get involved.  AI will inevitably change the way we work; for many people, it already has. However, there are some principles that never change.  There will still be 24 hours in a day, you will still be able to only focus on one thing at a time, and you won't be able to be in more than one place at a time.  Your energy will fluctuate, and you will need to get enough sleep.  The need to manage our time is still there. We still have friends and family, work commitments and perhaps some hobbies. They all need time.  And the principles of time management will not change. If you want to do something, it will require time. Whether that's cleaning out your car or sitting on the sofa chatting with an AI bot.  Time management and productivity skills will still be needed no matter what advances AI brings to our workplaces and lives. Thinking about all this led me to look at how people are engaging with my Learning Centre. This is where I have courses and programmes to help people become better at managing their time and become more productive.  As I was looking, I noticed something interesting. The people who have made the biggest positive changes in their lives weren't the people who bought the most courses.They were the people who kept learning. They perhaps began with my COD course, my free productivity fundamentals course, then went on to purchase the Time and Life Mastery programme or the Time Sector System course.  Some went on to join my coaching programme so they could have guidance on building their own, tailor-made system.  This highlighted a mistake many people make with time management and productivity. They approach it as if it were a destination. Find the perfect app, read the right book, take the right course, watch one more YouTube video, then they'll finally be organised. Yet that's not how it works, and you've probably noticed. A few years ago, the trend was minimalist desk set-ups. This is where people stripped everything from their workspace so all they had was a small plant, a simple lamp and a laptop attached to a large monitor.  YouTube was full of videos of people showing off their desk setups. They looked great, but did absolutely nothing for their productivity.  Now the trend is to have books and notebooks everywhere. The plants survived, but the little desk accessories have reappeared. Minimalism seems to have lost its appeal. Few people have been able to stick with it.  It seems keeping things minimal is challenging and time-consuming. I also saw something similar when I was at university; I studied part-time. 6:00 pm to 9:00 pm every Tuesday and Thursday.  On our first day, there were just over 200 students crammed into the lecture theatre. All excitedly looking forward to their graduation day four years later with an LL.B Honours degree.  I remember the professor in charge of the course telling us that 70 to 80% of those in that lecture theatre would not graduate. Not because the course was particularly difficult. It wasn't. But because committing six hours a week to attending lectures for four years would be a commitment beyond most people.  And on our graduation day, there were just 24 students left. Almost 200 students had quit! It didn't matter what tools or processes you had. What mattered was understanding the basic principles of time management. Turning up consistently and doing the work.  It had nothing to do with academic ability or how smart someone was. The people who graduated were the ones who turned up constantly and managed their time so they were able to attend the lectures and do the reading (there was a lot of reading to do for a law degree) week after week for four years.  Being good at time management and consistently productive is more like fitness. Let's say you wanted to get fit. You wouldn't expect to take a three-hour course on weight training and suddenly become stronger.  Fitness doesn't work like that. The same is true of playing the piano, learning a language, cooking, and photography. These are not one-time learning experiences; they're continuous. And learning to better manage your time and be more productive is no different. Our lives and work change. We may begin as a junior administrative assistant, but within a year or two we are managing a team of four people and overseeing projects.  You start a family; now suddenly you have a little monster waking up every two or three hours screaming through the night. And as your kids grow up, you have commitments to take them to and pick them up from swimming or football practice.  The time management skills you learned at school and university don't work in the workplace. And as you change jobs, you need to learn new ways to manage your time both professionally and personally.  The real challenge isn't knowing what to do. If you've followed this podcast or my YouTube channel, you will already know you should plan your week and day, spend less time reacting to emails and messages, and protect time for your core work (at least I hope you do). The challenge is applying what you know consistently while juggling meetings, deadlines, family commitments and the unexpected events that arrive every day. This is why consuming more productivity content isn't going to create the change you want. As James Clear's Atomic Habits (a fantastic book) shows: Information fades; your habits remain. Over the years I've noticed something about many of the people I've coached. The ones that become brilliant at managing their time don't just complete a course or have one or two coaching sessions and disappear; they keep coming back. They ask questions, refine their systems, and they adapt as their careers and family lives change. They come back to ideas we implemented years ago and learn new ideas because they now have different challenges.  My best clients have been with me for over eight years, and they are the ones who've seen incredible changes, so much so that they've inspired me! I realise now that when my driving instructor told me years ago that: “You don't learn to really drive a car until you've passed your driving test.”  the same is true about your time management and productivity: you don't become more productive and better at managing your time until you start practising what you learned.  All this got me thinking about what productivity education should look like over the next five to ten years. I don't believe it's about creating more courses, and it's certainly not about developing more complicated systems, packaging them up and selling them.  Instead, it's about creating a place where people can continue learning, refining and improving over time, just like many of my coaching clients have done. They understand that becoming organised and in control of their time isn't a project; it's a lifelong commitment. And like every commitment, it works for those who stick with it. So, going forward, I will be introducing more live training events for you.  I started doing a few live training events in 2023, and some of my favourite moments have been in those sessions. I've been able to answer questions, explore new ideas and help people apply what they've learned to their own situations. Standalone courses don't allow me to do that, because we are all different, with different professions and responsibilities; no ‘one size' will fit everyone, and that's frustrating as a teacher.  Live training changes that. It gives you a place to ask me questions directly related to your challenges. That is what I want to make an ongoing part of the learning experience, not something that only happens occasionally. The courses and programmes give you the technical knowledge and theory. The live training gives you the practical skills to put what you learn in the courses into practice in ways that work for you.  It's the difference between learning to drive by reading a book or getting in a car with an instructor and actually going out there and driving. All this thinking led me yesterday to launch my Productivity Academy. It is the result of months of work, giving you a place where you can keep coming back, get answers to your questions, and work with a group of people on a similar journey as yourself.  And it includes monthly live training sessions that you can join, ask questions, and have the principles applied directly to the way you work.  It will also give you access to all my current and future courses, along with a recommended roadmap for taking them.  My overall goal hasn't changed. That's to help as many people as I can become better at managing their time and being more productive so they can enjoy the things they want to enjoy doing.  But I realise I need to do more, and the best way I can do that is to increase the live training element, which will allow me to help you navigate the current and future ways we work.  If you've already purchased several of my courses, please don't think you need to replace them. You don't. Those courses remain yours exactly as before. The Academy is simply a different way to learn. The courses will give you the theory and know-how. The Academy will give you the practical skills (and some accountability) to put what you have learned into practice. If you enjoy learning independently, nothing changes. If, however, you'd like regular guidance, monthly training and access to everything I create going forward, I think you'll really enjoy becoming an Academy Member.  I will put a link in the show notes to the Academy's website, and feel free to email me if you have any questions.  I hope to be able to “meet” you in one of our live training sessions soon.  Thank you for listening, and it just remains for me to wish you a very, very productive week.   

Brain cancers are rare, but devastating. Patients face short life expectancies after diagnosis. Brain tumors are often impossible to remove completely. And radiation and chemotherapy don't always stop them from spreading.  It's a daunting class of disease to study, but that didn't dissuade Michelle Monje from trying. She has spent two decades studying how brain tumors form and interact with healthy brain cells, and pioneered the field of cancer neuroscience.  Guest: Dr. Michelle Monje is a professor of pediatric neuro-oncology at Stanford Medicine.  Other episodes you may enjoy: Promising new treatments for pancreatic cancer and ALS The new frontier of cancer research is in space Transcripts for each episode are available within 1-3 days at sciencefriday.com. Subscribe to this podcast. Follow our show on Instagram, TikTok, Facebook, and Bluesky @scifri and sign up for our newsletters. Got a science question that's keeping you up at night? Call us: 877-472-4374 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Mike, Ali, and Beau react to all the news that came out of day two of Atlanta Falcons training camp, and explain why they think Atlanta Falcons quarterback Michael Penix Jr. saying that doctors told him that he's ahead of schedule is a promising sign.

Listen to #Pulse95Radio in the UAE by tuning in on your radio (95.00 FM) or online on our website: www.pulse95radio.net ************************ Follow us on Social. www.instagram.com/pulse95radio www.facebook.com/pulse95radio

Today we welcome Gene Mack, President and CEO of Gain Therapeutics. With over 25 years of experience spanning biochemistry, Wall Street analysis, and biotech leadership, Gene brings deep expertise in capital markets, strategy, and drug development. He joined Gain in 2024 and stepped into the CEO role in early 2025.Gain Therapeutics is a clinical-stage biotech pioneering next-generation allosteric small molecule therapies. Using its proprietary Magellan platform, which combines 3D structural biology and physics-based modeling, the company is unlocking novel treatments for challenging disorders. Their lead candidate is advancing toward Phase 2 as a potential first-in-class disease-modifying therapy for Parkinson's disease, with promising Phase 1b data showing biomarker improvements and functional benefits.In this episode, we'll explore Gene's journey, Gain's innovative strategy, the Parkinson's landscape, and the future of AI in biotech.·  01:28 Meet Gene Mack ·  11:15 GAIN's mission: disease modification over symptom relief ·  17:07 Why existing Parkinson's therapies fall short ·  22:39 Origins and evolution of the Magellan platform ·  26:16 How AI changes drug discovery beyond just speed ·  28:13 Phase 1b study design and open-label extension results ·  32:09 Partnership strategy and path to Phase 2 ·  35:29 Advice for leaders in neurodegeneration Interested in being a sponsor of an episode of our podcast? Discover how you can get involved here! Stay updated by subscribing to our newsletterTo dive deeper into the topic: Promising biotechs in Maryland right nowBeyond amyloid and dopamine: emerging technologies reshaping neurology  Neurological diseases R&D trends and breakthrough innovations

Confession: Open-minded medicine must still be evidence-based medicine. Did the FDA just approve BPC-157 and other popular peptides? Not exactly and that distinction matters. Following a closely watched FDA advisory committee meeting, headlines and social media posts began suggesting that peptides such as BPC-157, TB-500, KPV, MOTS-c, Epitalon, and Semax had been "approved" or "unbanned." Let's be clear: An advisory committee recommendation is not the same thing as FDA approval, proven effectiveness, or established long-term safety. In this episode of Confessions of a Male Gynecologist, Americas Holistic Gynecologist, Dr. Shawn Tassone explains what the recent FDA peptide vote actually means, what could happen next, and why patients and practitioners should be careful about confusing expanded compounding access with scientific validation. Peptides are increasingly promoted online for injury recovery, inflammation, gut health, mitochondrial function, metabolism, sleep, longevity, cognitive performance, this list goes on...  Some have interesting biological mechanisms and promising preliminary research, but many of the claims being made online extend far beyond the available human evidence. In this episode Dr. Tassone examines: BPC-157: Why its reputation as a powerful healing peptide has grown faster than the quality of the human research. KPV: Its proposed anti-inflammatory benefits and the lack of meaningful clinical studies in humans. TB-500: Why it is frequently confused with thymosin beta-4 and why the distinction matters when evaluating research. MOTS-c: The growing interest in its potential mitochondrial and metabolic effects and the questions that remain unanswered. Epitalon: Claims involving sleep, longevity, and anti-aging versus the strength of the available evidence. Semax: Why having more reported human exposure does not automatically mean the research meets modern clinical standards. The FDA's 503A Bulk List: What pharmacy compounding access means and what it does not mean. Peptide Marketing: How experimental therapies can begin sounding proven long before adequate safety and effectiveness data exist. Promising mechanisms deserve research, patient experiences can help generate better questions, but neither should be used as a replacement for rigorous human trials, reliable manufacturing standards, appropriate medical oversight, and honest conversations about uncertainty. Before assuming that a favorable committee vote means a peptide is now FDA approved, safe, or clinically proven, listen to this episode for the full context, share this episode with someone considering peptide therapy, and leave a rating or review to help more people find evidence-based conversations about their health and hormones! Episode Resources: Work with Dr. Tassone | Tassone Advanced Gynecology Please contact the clinic directly at (512) 956- 0296 with all scheduling inquiries. Purchase Dr. Tassone's Best-Selling Book | The Hormone Balance Bible Dr. Tassone's Integrative Hormonal Archetype Quiz | Discover Your Hormonal Archetype Medical Disclaimer This podcast and website represent the opinions of Dr. Shawn Tassone and his guests. The content here should not be taken as medical advice and is for informational purposes only. Because each person is so unique, please consult your health care professional for any medical questions.

The New Orleans City Council will soon have more control over the Sewerage and Water Board. Council President JP Morrell says changes are coming.

Robert Saleh is reportedly predicting that Tennessee will beat the Jets in Week 1, and Evan Roberts, Tiki Barber and Shaun Morash immediately turn his trash talk into bulletin-board material. With Garrett Wilson preparing to catch passes from yet another quarterback and Cade Klubnik already generating training camp buzz, the Jets' endless search for stability remains impossible to ignore. The bigger concern is Aaron Glenn's defense. Eight new starters, questions about the overall talent and Glenn taking over the play-calling create enormous pressure for a team that may finally have enough offensive weapons to surprise people. The conversation then turns to a franchise-changing possibility: abandoning the rookie-quarterback cycle and pursuing Baker Mayfield if he ever becomes available.

— IN THE TRANSITS: —July 27 (Mon) Sun opposing Pluto Rx: The PowerfulJuly 27 (Mon) Sun trine Neptune Rx: Intuition CountsJuly 27 (Mon) Sun sextile Uranus: Joining with OthersJuly 29 (Wed) Venus square Mars: Magnetic PulseJuly 29 (Wed) Sun conjunct Jupiter: Days Like ThisJuly 29 (Wed) Full Moon at 6° Aquarius: Wildly Active & Promising(Central Time for all dates & times) Follow along with these transits personally! Download the Astrology Guide:https://intentionbeads.com/products/free-astrology-guideDownload your Natal Chart:https://intentionbeads.com/chartBook Your Reading with $20 Off (code: PODCAST):https://intentionbeads.com/book— TALISMAN TIMES: — #1942 - (July 30th) To honor the power of partnership.ALL PRE-SALE TALISMANS: https://intentionbeads.com/collections/pre-sale-talismans— ON THE HORIZON: —August Astrology Forecast (August 1)Watch now: https://www.youtube.com/watch?v=OM57O75UnH8August Cheat Sheet: https://intentionbeads.com/products/sandy-susans-astrology-date-cheat-sheetSeptember 3 - 8, 2026 Chicago UAC: United Astrology ConferenceMarriott Downtown, Chicago IL Buy your tickets here: https://uacastrology.com/uac-2026-registration/September 13 - 26, 2026 Egypt RetreatSign Up Today: https://intention.wetravel.com/trips/egypt-2026-sandy-rueve-intention-beads-58293624Schedule your free retreat call here: https://intentionbeads.as.me/retreat— OUR HOUSE: —Have you seen it yet? Let's hear Sandy's take on the Odyssey.

In this episode, we break down two governance proposals currently up for vote (ADR 29 and ADR 31), dive into revenue sharing and dynamic fees, and cover the latest updates across several upcoming chains.Swap now https://swap.thorchain.org/ THORChain is a decentralized crypto exchange. THORChain is the first and biggest DEX for Bitcoin. You can use any self custody wallet to swap and there's no KYC required.Timestamps:00:00:00 Intro00:03:00 Miradex shoutout00:05:00 Marketing update00:09:00 XMR publication strategy00:10:00 Chad met someone with close ties to Trezor00:11:00 Robinhood made its platform available for AI agents00:12:00 AI compatibility with STO00:13:00 Chad B talks about the conference00:14:00 Chad B has someone who wants to meet Kenton for a documentary00:17:00 THORDex.io may be a scam — be careful00:19:00 THORWallet won a patent case over the THORChain brand00:21:00 ADR 29 discussion (revenue sharing)00:22:00 Some integrators prefer revenue sharing over affiliate fees00:25:00 SwapKit revenue sharing looks promising and could drive more volume00:27:00 More integration tools will make Randy's BD role easier00:28:00 44 new partners want widget/API access00:31:00 Analytics tab is ready for integrators to track generated revenue00:33:00 Why API access is whitelisted00:34:00 Integrators can run their own infrastructure instead of using the API00:35:00 ADR 31 discussion00:36:00 Formalizing the relationship helps integrators build a roadmap00:37:00 Kenton explains why he changed his opinion on the app layer since ADR 2000:39:00 Permissioned access is more secure00:40:00 Merger discussion00:43:00 Why merging would be complicated00:45:00 The power of collaboration00:54:00 When will the protocol return to normal?00:55:00 XMR update — lots of edge cases and fixes00:56:00 When is Zcash coming?00:57:00 Once churn is working, Zcash can be added00:58:00 Bittensor (TAO) update01:00:00 Dynamic fee update — Symbiosis was disabled due to a bug01:02:00 Screen share of Rayyk's affiliate page01:04:00 90% of generated fees came from revenue sharing — huge volume increase01:06:00 THORChain is performing much better with dynamic fees01:07:00 Promising initial data01:09:00 THORChain vs. Chainflip pool price comparison01:11:00 App Layer design to improve price execution01:14:00 Great job, Chad!01:18:00 Signal vs. noise considerations with revenue sharing01:20:00 SwapKit partnership could be much more effective01:23:00 It will also drive more volume for SwapKit01:27:00 Start simple and keep the variables limited01:29:00 Deepen the Tron.USDT pool? (POL?)01:31:00 How have Rapid Swaps been performing? Are we ready for version 3?01:37:00 Devel's proposal and its synergy with dynamic fees01:39:00 MEV concerns01:43:00 A tip mechanism may address MEV concerns01:49:00 Let's finish our current ADRs01:52:00 Maximum effective bond — increase to 2 million?01:54:00 Multi-node operators vs. single-node operators with a single vault01:57:00 When can integrators expect revenue sharing?02:00:00 Revenue sharing presents a lot of opportunity02:04:00 AI agents and revenue sharing02:06:00 Separate STO API interface for AI agents using JSON

Bongani Bingwa speaks with Thuli Magubane, Founder and Director of MintFresh Technology Solutions, and Alan Shannon, Executive Head: Small Business Services and Private Clients at Nedbank, to wrap up this year's Nedbank's Business Ignite campaign. 702 Breakfast with Bongani Bingwa is broadcast on 702, a Johannesburg based talk radio station. Bongani makes sense of the news, interviews the key newsmakers of the day, and holds those in power to account on your behalf. The team bring you all you need to know to start your day Thank you for listening to a podcast from 702 Breakfast with Bongani Bingwa Listen live on Primedia+ weekdays from 06:00 and 09:00 (SA Time) to Breakfast with Bongani Bingwa broadcast on 702: https://buff.ly/gk3y0Kj For more from the show go to https://buff.ly/36edSLV or find all the catch-up podcasts here https://buff.ly/zEcM35T Subscribe to the 702 Daily and Weekly Newsletters https://buff.ly/v5mfetc Follow us on social media: 702 on Facebook: https://www.facebook.com/TalkRadio702 702 on TikTok: https://www.tiktok.com/@talkradio702 702 on Instagram: https://www.instagram.com/talkradio702/ 702 on X: https://x.com/Radio702 702 on YouTube: https://www.youtube.com/@radio7See omnystudio.com/listener for privacy information.

South Africa's entrepreneurs continue to turn real-world challenges into innovative businesses. Nedbank's Business Ignite in partnership with CapeTalk has once again celebrated the country's most promising small businesses. After receiving more than 740 entries from across the country, two outstanding businesses have been named the 2026 winners. Today, we're joined by Alan Shannon, Executive: Nedbank Private Wealth, Private Clients & Small Business, to reflect on this year's campaign, celebrate the winning businesses, and discuss why supporting entrepreneurs remains central to Nedbank's commitment to helping South African businesses grow and thrive. Good Morning Cape Town with Lester Kiewit is a podcast of the CapeTalk breakfast show. This programme is your authentic Cape Town wake-up call. Good Morning Cape Town with Lester Kiewit is informative, enlightening and accessible. The team’s ability to spot & share relevant and unusual stories make the programme inclusive and thought-provoking. Don’t miss the popular World View feature at 7:45am daily. Listen out for #LesterInYourLounge which is an outside broadcast – from the home of a listener in a different part of Cape Town - on the first Wednesday of every month. This show introduces you to interesting Capetonians as well as their favourite communities, habits, local personalities and neighbourhood news. Thank you for listening to a podcast from Good Morning Cape Town with Lester Kiewit. Listen live on Primedia+ weekdays between 06:00 and 09:00 (SA Time) to Good Morning CapeTalk with Lester Kiewit broadcast on CapeTalk https://buff.ly/NnFM3Nk For more from the show go to https://buff.ly/xGkqLbT or find all the catch-up podcasts here https://buff.ly/f9Eeb7i Subscribe to the CapeTalk Daily and Weekly Newsletters https://buff.ly/sbvVZD5 Follow us on social media CapeTalk on Facebook: https://www.facebook.com/CapeTalk CapeTalk on TikTok: https://www.tiktok.com/@capetalk CapeTalk on Instagram: https://www.instagram.com/ CapeTalk on X: https://x.com/CapeTalk CapeTalk on YouTube: https://www.youtube.com/@CapeTalkSee omnystudio.com/listener for privacy information.

Migration was at the heart of Giorgia Meloni's successful 2022 election campaign. Promising a tougher approach to irregular migration helped propel her to power, but what has her government achieved since then? One of its flagship policies was the creation of a controversial migrant processing centre in Albania. Yet the plan has repeatedly run into legal obstacles in Italy, raising questions about whether it can deliver on its promises. At the same time, Meloni has had to balance her hardline rhetoric with economic realities. Faced with labour shortages and pressure from businesses, her government has authorised around half a million additional work visas for the 2026–2029 period. Has Meloni's migration policy proved more pragmatic than her supporters expected? Whatever the answer, it has created political space on her right. One of the most prominent challengers is former army general Roberto Vannacci, who advocates an even tougher approach to immigration and openly calls for the "remigration" of migrants. Luke Brown reports.

The monsoon season is off to a promising but intense start in Montezuma County.

This week we sink our teeth into Evil Dead Burn, the latest installment in the legendary Evil Dead franchise. Promising a fresh setting, new victims, and all the blood-soaked chaos fans have come to expect, this chapter looks to continue the series' tradition of relentless possession horror while forging its own identity. We discuss what makes the Evil Dead franchise so enduring, our first impressions of this new entry, and how it stacks up against classics like Evil Dead II, the 2013 remake, and Evil Dead Rise. From gruesome practical effects and inventive Deadite mayhem to the franchise's signature blend of terror and dark humor, we break down whether Evil Dead Burn keeps the series' fiery momentum alive. Join us as we unpack the scares, the carnage, and why the Book of the Dead continues to unleash some of horror's most unforgettable nightmares.   Follow Us on ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠: @horrorhourwiththehannas   Music by Aries Beats - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.youtube.com/watch?v=DPpnxLYrzVA⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠   #horrorpodcast #horrormovies #horrorfilm #scarymovie #scarymovies #scarymoviesbelike #horrortok #horrorhour #behindthescenes #howscary #moviereview #filmreview #morbidpodcast #creepypodcast #filmtok #moviesummary #horrorpodcast #horrormovies #horrorfilm #scarymovie #scarymovies #scarymoviesbelike #horrortok #horrorhour #behindthescenes #howscary #moviereview #filmreview #morbidpodcast #creepypodcast #moviesummary #movieexplained #scary #horror #movie #film #behindthescenes #behindthescene #filming #moviefacts #halloween #filmpodcast #horrorfilmanalysis #filmpodcast #horrorgenre #horrorfilmanalysis #newrelease #horrormoviepodcast #evildeadrise #evildeadburn

Bungie built the defining live shooter of the decade, then spent ten years surviving its own crises. This one plays like the eulogy.The crew runs the full ups and downs of Bungie from Myth to Marathon, with an ex-Bungie insider walking through every near-death moment, why Destiny endured far longer than anyone predicted, why it finally fell off, and whether Sony and Marathon can pull the studio back from the edge.Topics Covered:• The end of Destiny and whether Bungie is actually done• The hot take that Xbox is in decline and Bungie should return to make Halo• The full Bungie crisis history from the Myth 2 uninstaller disaster to Marathon• The internal Destiny Supercut that blew up 14 months before launch• The Taken King and Forsaken redemption arcs• Sony's acquisition, the Lightfall flop, and The Final Shape as the ending• Why Destiny survived when its narrative and monetization kept misfiring• The free-to-play misfit problem and DLC warbond monetization• Promising the future as the real retention engine• The maintenance mode debate for aging live service shooters• What Marathon actually needs to rebound

Worship with us live online at ExploreGracePoint.com/church-onlineGracePoint Church2351 Rice Creek RdNew Brighton, MN 55112

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're navigating through a myriad of transformative advancements reshaping the industry. From artificial intelligence-driven research breakthroughs to strategic acquisitions in emerging therapeutic areas, these developments are setting new benchmarks in drug discovery and patient care. **Strategic Acquisitions and Expansions:** Samsung Biologics' recent proposal to acquire Swiss CDMO Polypeptide for $1.8 billion marks a significant expansion into peptide production, underscoring the growing therapeutic importance of peptides. Their specificity and efficacy make them particularly appealing for metabolic disorders such as obesity. This acquisition reflects a strategic move to capture emerging market opportunities as demand for innovative metabolic treatments rises. Eli Lilly's bold $2.8 billion acquisition of Atai-Beckley highlights the pharmaceutical industry's shifting focus towards psychedelics. As mental health disorders like depression and PTSD become more prominent, psychedelics hold great promise for new therapeutic approaches. This acquisition may pave the way for further research and acceptance of psychedelics within mainstream medicine, offering new hope for patients. Another notable development is Tempus' acquisition of Personalisis for $1.5 billion. This move strengthens Tempus' cancer treatment portfolio by leveraging genomics-driven insights, emphasizing precision medicine's critical role in oncology. **AI Integration and Technological Innovation:** Bristol Myers Squibb is doubling down on AI integration by expanding its collaboration with Nvidia to build what promises to be the most powerful AI supercomputer dedicated to life sciences. This development is pivotal as it signifies a deeper commitment to harnessing computational power in R&D. By accelerating drug discovery and optimizing clinical trial processes, AI stands to revolutionize how treatments are developed and tailored to individual patients. Overall, these developments indicate a dynamic phase characterized by technological innovation and strategic collaborations. The integration of AI into drug development processes stands out as a transformative force, promising enhanced efficiency and efficacy in bringing new treatments to market. **Regulatory Milestones and Clinical Trials:** In regulatory news, Takeda's Qdenga has achieved a milestone by becoming India's first approved dengue vaccine. This approval is crucial in addressing neglected tropical diseases, with significant implications for public health in regions where dengue is prevalent. By reducing dengue fever incidence, this vaccine could play a vital role in improving health outcomes in many tropical countries. Promising results have emerged from clinical trials across various therapeutic areas. 4D Molecular Therapeutics reported an 87% reduction in treatment burden for wet AMD using their gene therapy candidate 4D-150 in Phase 2b trials—demonstrating potential as a transformative approach with reduced intervention frequency. Latigo Biotherapeutics' Nav1.8 inhibitor LTG-001 outperformed Vicodin in Phase 2 trials for acute pain, offering a non-opioid alternative amidst the opioid crisis. Meanwhile, Regenxbio's five-year data on surabgene lomparvovec shows sustained efficacy in wet AMD and diabetic retinopathy—underscoring its potential as a long-term treatment option. **Financial Performance and IPO Activity:** Financially, Abbott exceeded expectations with strong sales from their device and diagnostic divisions, prompting an upward revision of their full-year profit forecast. This reflects sustained demand for innovative diagnostic solutions and medical devices—highlighting Abbott's strategic market positioning. The IPO landscape remains active with companies like Nuvox Therapeutics seeking to raise funds for advancing oxygen therapeutics targeting hypoxia-related diseases—showcasing renewed investor interest and confidence within biotech innovation. Latigo Biotherapeutics is preparing for an IPO to advance its pipeline, demonstrating a strategic response to the opioid crisis. By developing alternatives that minimize addiction risks while providing effective relief, Latigo underscores the industry's commitment to safer pain management solutions. Turning to clinical trials, Scribe Therapeutics plans a $96 million IPO to advance its CRISPR-based lipid-lowering therapies, marking significant interest in genetic solutions for cardiovascular diseases like hyperlipidemia. The precision offered by CRISPR technology could revolutionize treatment options for conditions contributing significantly to cardiovascular health burdens. **Geopolitical Influences:** Geopolitical factors are also influencing market dynamics, particularly in the UK biotech sector where IPO plans are being shaped by global uncertainties despite robust venture capital backing. This situation underscores the complex interplay between regional economic conditions and global investment trends in biotech innovation. As these trends continue unfolding across the industry landscape—from AI-driven research advancements to strategic acquisitions—the potential impact on patient care paradigms remains profound. These developments not only promise new possibilities within drug development but also influence broader healthcare delivery models aimed at improving patient outcomes globally.Support the show

Episode 387 Two big interstellar discoveries have hit the headlines. One is the discovery of the first atmosphere ever found on a small, rocky exoplanet that could host alien life. The planet LHS 1140b is about 50 light years from Earth and sits in the “Goldlocks” zone, meaning it's close enough to its star to be habitable. So what do we know about its atmosphere – and could it be just like Earth? The second story is of sugar molecules discovered in interstellar space for the first time – detected in a cosmic cloud nearly 27 light years away. Researchers believe this sugar could have formed before the solar system itself. Find out more with Senior Editor Chelsea Whyte and Space Reporter Leah Crane. To read more about these stories, visit https://www.newscientist.com/ Image credits: Chester Harman, CC BY-SA 4.0 https://creativecommons.org/licenses/by-sa/4.0 via Wikimedia Commons ESO/spaceengine.org, CC BY 4.0 https://creativecommons.org/licenses/by/4.0 via Wikimedia Commons Learn more about your ad choices. Visit megaphone.fm/adchoices

Scott and a mourning JB go through the week's biggest news stories. Hosted on Acast. See acast.com/privacy for more information.

Earnings from TSMC (TSM) are "incredibly solid," says Stephen Sopko, believing the company making two-thirds of its revenue from "leading edge" AI chips shows strength in the tech trade. He explains why the report is "incredibly promising" for the AI trade, so long as TSMC delivers on execution in meeting robust demand. One supply risk it faces: power, something Stephen calls "the primary" factor behind how the AI buildout continues from here.======== Schwab Network ========Empowering every investor and trader, every market day. Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribeDownload the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watchWatch on Vizio - https://www.vizio.com/en/watchfreeplus-exploreWatch on DistroTV - https://www.distro.tv/live/schwab-network/Follow us on X – https://twitter.com/schwabnetworkFollow us on Facebook – https://www.facebook.com/schwabnetworkFollow us on LinkedIn - https://www.linkedin.com/company/schwab-network/ About Schwab Network - https://schwabnetwork.com/about======== Schwab Network ========Empowering every investor and trader, every market day. Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribeDownload the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watchWatch on Vizio - https://www.vizio.com/en/watchfreeplus-exploreWatch on DistroTV - https://www.distro.tv/live/schwab-network/Follow us on X – https://twitter.com/schwabnetworkFollow us on Facebook – https://www.facebook.com/schwabnetworkFollow us on LinkedIn - https://www.linkedin.com/company/schwab-network/ About Schwab Network - https://schwabnetwork.com/about

Liz Peek highlights the rise of the Democratic Socialists of America as a significant threat to established Democraticincumbents. Young voters are flocking to radical platforms promising free services. Rahm Emanuel emerges as a blunt voice for the party, urging a challenge against these "loons." (2)STEEL BRIDGE PS

Worship with us live online at ExploreGracePoint.com/church-onlineGracePoint Church2351 Rice Creek RdNew Brighton, MN 55112

Dr Sira Karvinen - Sweat analysis | Exercise | Future applications Sira Karvinen currently works at the Gerontology Research Center, University of Jyväskylä, Finland. She is a postdoctoral researcher in a EsmiRs-study - Risk of metabolic dysfunction in middle aged women: systemic and intracrine oestrogen and microRNAs as mediating factors. --- This podcast episode is sponsored by Fibion Inc. | The New Gold Standard for Sedentary Behaviour and Physical Activity Monitoring Learn more about Fibion: fibion.com/research --- Physical Activity Researcher Podcast have created a ‘Purchase Guide for Researchers: Accelerometer-based Activity Trackers'. You can download it from here. ---

Oran P. Smith on South Carolina's changing attitudes about taxation

ACT expects the prison population to grow under its policy of cracking down on burglars - but says it's necessary. The Party wants a mandatory three-year prison sentence for offenders convicted of burglary three times, claiming judges are too lenient in sentencing. Deputy Leader Nicole McKee says it's clear changes need to be made, and repeat offenders will need to face punishment. "We've said - enough is enough, and we want to make some changes here, make people accountable, put victims first and give the opportunity for New Zealanders to feel safe in their own homes." LISTEN ABOVESee omnystudio.com/listener for privacy information.

GOOSE and the promise of a “better” gay app Allegations around AI-generated or inauthentic promotional accounts Why fake intimacy feels especially insulting in queer spaces The difference between marketing, fantasy, and manipulation Dating app fatigue and the hunger for real-life gay community Invite-only culture, social status, and who gets to belong Why hookup culture is not the enemy Meetup groups, gay social clubs, and the return of offline connection The business of gay loneliness — and why we keep buying in Hot Topic: Turkey bans Atlantis Cruise from docking... Hot Topic: A gay couple experienced homophobia at a baseball game that was supposed to be date night... Hot Topic: Would you stay at Lisa Vanderpumps new hotel in Vegas? Hot Topic: Speedos or Trunks this Summer? Plus Luke Evans rocks both! Hot Topic: Stonewall Veteran Victoria Cruz dies and Pansexual Adult Performer Dale Savage suddently dies at 62 from a Stroke. Advice: A boy in every port sounds great but now he's debating settling down... Follow Steve V's new Substack features weekly articles: https://substack.com/@thenakedtruthsteve Follow Stevie on IG: @iam_stevev Follow Jeremy on IG: @jrosslopez Follow Kodi on IG: @mistahmaurice Rate and Review us! Wanna drop a weekly or one time tip to TAGSPODCAST - Show your love for the show and support TAGS! Visit our website: tagspodcast.com Needs some advice for a sex or relationship conundrum? Ask TAGS! DM US ON IG or https://www.talkaboutgaysex.com/contact Follow Of a Certain Age on IG: @ofacertainagepod Episode Question: Are gay men really looking for another app, or are we just looking for more honest ways to meet each other? Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Geoffrey Wawro, guest author, details how Richard Nixon derailed peace talks in 1968 through Anna Chennault, promising South Vietnamese President Thieu a "better deal" to prevent a "November surprise" for Hubert Humphrey. This move resulted in the war continuing for four more years, costing 28,000 additional American lives for essentially the same peace terms available in 1968. Under Nixon, the 1969 Battle of Hamburger Hill highlighted the continued reliance on the "search and destroy" doctrine despite its heavy costs. Waves of American troops were sent against prepared bunkers for a hill with no strategic value, sparking a domestic outcry led by figures like Ted Kennedy. Furthermore, the segment notes the ineffectiveness of South Vietnamese local militias ("Ruff Puffs"), which were often infiltrated by the Viet Cong and frequently avoided combat despite being heavily armed by the US. The Vietnam War: A Military History(5)

Worship with us live online at ExploreGracePoint.com/church-onlineGracePoint Church2351 Rice Creek RdNew Brighton, MN 55112

Professor Evan Ellis reports that Keiko Fujimori is the declared victor in Peru's election, promising a pro-security, pro-U.S. agenda despite continued economic ties with China. Meanwhile, Bolivia remains unstable as President Rodrigo Paznavigates an economic crisis, currency devaluation, and ongoing pressure from former leader Evo Morales. (11)1857 VENEZUELA

Summer is here. The humidity is oppressive. Your shoes are permanently damp. Your long run started three hours ago and somehow you're still not back at the car. This week on The Running Mullet, we're talking about maintaining your mojo in midsummer. When the novelty of race season wears off, the weather gets brutal, and the training calendar starts feeling more like a chore than an adventure, how do you keep showing up? We want your stories:

In this episode, Anthony and Bernie are joined by the great Dr. Bixby to discuss the difficulties in the diagnosis and treatment of acute leukemias of mixed or ambiguous lineage (ALAL/MPAL). We discuss:- Diagnostic uncertainties and how the criteria for diagnosis have changed over the years- Data behind the optimal treatment of MPAL and uncertainties in the literature- Promising data for the FLAG-VIPR hybrid regimen and other novel treatment strategies

Worship with us live online at ExploreGracePoint.com/church-onlineGracePoint Church2351 Rice Creek RdNew Brighton, MN 55112

Ursolic acid is a natural plant compound found in foods like apple peels and herbs, and it is often promoted for muscle growth, strength, fat loss, IGF-1, mTOR signaling, and exercise performance. In this episode, we look at the human research on ursolic acid supplements, including resistance training studies, muscle biopsy data, anabolic signaling, body fat changes, strength results, and possible side effects. Does ursolic acid really help people build muscle and get stronger, or is the evidence still too limited? Let's break down what the science actually says.ReadMy Rhabdo BooKOrder onAmazon (affiliate link)Consultations https://supplementclarity.com/private-consultations/Connect With MeSupplementClarity.com  YouTubeTiktokAbout  Since the 1990s I've been sorting nutrition facts from fiction and helping people understand dietary supplements, using clinical research as my litmus test. I am independent and unbiased. I analyze the research so you don't have to.  I wrotethe first book about exercise-induced rhabdomyolysis. I have an MS in exercise science and a BS in biology & chemistry.   Disclaimer Episodes are for informationonly. I'm NOT a medical doctor. NO medical advice is given or implied. ALWAYSconsult your physician for the best health advice for you. I participate in theAmazon Associates program which means if you click on a link to amazon and makea purchase, I may make a small commission at no extra cost to you.

Pancreatic cancer is among the most deadly forms of cancer, and it can be difficult to catch early. But there's some good news: Clinical trials of a new drug called daraxonrasib found that it doubled the survival time of patients with advanced pancreatic cancer. And some oncologists are calling it a game changer—not just for pancreatic cancer, but potentially other forms of cancer too. Ira talks with oncologist Zev Wainberg, who led a clinical trial for the drug.  Plus, ALS is a degenerative disease that causes patients to lose their ability to walk, swallow and eventually to breathe. Now, there's a drug for a rare genetic form of ALS that can slow the progression or even reverse some of these symptoms. Ira talks with New York Times health and science reporter Pam Belluck about this new treatment. Guests: Dr. Zev Wainberg is a co-director of UCLA Health's GI Oncology Program. Pam Belluck is a health and science reporter for The New York Times. Other episodes you may enjoy: mRNA Vaccine For Pancreatic Cancer Continues To Show Promise How do clinical trials work, and who can participate? Transcripts for each episode are available within 1-3 days at sciencefriday.com. Subscribe to this podcast. Follow our show on Instagram, TikTok, Facebook, and Bluesky @scifri and sign up for our newsletters. Got a science question that's keeping you up at night? Call us: 877-472-4374 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Colombia's Presidential Shift Toward Security and Law and Order. Guest: Evan Ellis. Abelardo de la Espriellaappears to have won the Colombian presidency, promising a crackdown on insecurity and organized crime modeled after El Salvador's policies. His victory signals a likely return to strong security cooperation with the United States and a departure from the policies of Gustavo Petro. 91900 MEXICO

National is promising to power up New Zealand homes if re-elected, with a loan scheme to encourage households to convert to solar and make energy efficiency improvements. The Home Energy fund would offer long term loans, at below market interest rates, so people can invest in the likes of solar, battery storage and insulation. The idea is a version of a scheme proposed by LGNZ and renewable energy advocates Rewiring Aotearoa. Mike Casey from Rewiring Aotearoa spoke to Lisa Owen.

As a veteran of the music and entertainment industry, David Nathan has helped shape the careers of A-list artists including Taylor Swift, Amy Winehouse and Ariana Grande.But behind that success, he faced a loss he never could have imagined. His son took what he believed was a Percocet, unaware it was laced with fentanyl, and died at just 19.Now, Nathan is focused on his most personal work yet: helping others navigate mental health challenges in his son's honor.What makes that mission even more meaningful is that it began with his son. Before his death, he founded an apparel company called Happy Jack, donating a portion of proceeds to support children facing mental health struggles.In this episode of Grieving Out Loud, Nathan shares his son's story, what he hopes other parents can learn, and how he's carrying forward a mission rooted in love, loss and purpose.Visit the Happy Jack website. Watch The Risks are Real live assembly here.Related episodes: Promising young entrepreneur dies after taking counterfeit PercocetThe Voice You Knew — The Story You Didn'tWhen Men Don't Cry: Confronting the Culture of Silent GriefSend us Fan MailBehind every number is a story of a life cut short, a family shattered, and a community devastated.They were...daughterssonsmothersfathersfriendswiveshusbandscousinsboyfriendsgirlfriends.They were More Than Just A Number. Support the showConnect with AngelaFollow Grieving Out LoudFollow Emily's HopeRead Angela's BlogSubscribe to Grieving Out Loud/Emily's Hope UpdatesSuggest a GuestFor more episodes and information, just go to our website, emilyshope.charityWishing you faith, hope and courage!Podcast producers:Casey Wonnenberg King & Kayli Fitz

In Real Men on Top: How Patriarchy Shapes Our Reality (Oxford University Press, 2026), Robin Dembroff shows us that we don't just live in a patriarchal world. We live in a world that patriarchy taught us to see. Patriarchy is not simply a system where men dominate women, Dembroff argues. It is a deeper reality-shaping force that legitimizes economic exploitation, political injustice, and social cruelty by dividing all of us into the rigid categories of Man, Woman, Animal, and Child. These categories are presented as natural truths, but Dembroff reveals them as man-made myths--ones that construct a reality in which being characterized as Woman, Animal, or Child marks moral degradation. By no coincidence, feminization, dehumanization, and infantilization are the very degradations used to make a man 'less of a man'. But this book is more than critique; it's also a guide to transformation especially for those grappling with what it means to be a man under patriarchy. Patriarchy's myths celebrate the identity Man, but these myths are no friend to most men. Promising strength and superiority, they instead fuel isolation, emotional repression, and relentless pressure to prove oneself while propping up systems that enrich the powerful few. Rather than deliver freedom and prosperity, these myths entrap and impoverish. Real Men on Top invites readers to see through them and, in so doing, to find new possibilities for living, relating, and becoming human. Sharp, daring, and deeply felt, Real Men on Top is a book for anyone who senses that something is deeply wrong with the way we live and wants to understand how we got here, and where we might begin the work of remaking reality. Robin Dembroff is an Associate Professor of Philosophy at Yale University Caleb Zakarin is CEO and Publisher of the New Books Network. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/new-books-network

In Real Men on Top: How Patriarchy Shapes Our Reality (Oxford University Press, 2026), Robin Dembroff shows us that we don't just live in a patriarchal world. We live in a world that patriarchy taught us to see. Patriarchy is not simply a system where men dominate women, Dembroff argues. It is a deeper reality-shaping force that legitimizes economic exploitation, political injustice, and social cruelty by dividing all of us into the rigid categories of Man, Woman, Animal, and Child. These categories are presented as natural truths, but Dembroff reveals them as man-made myths--ones that construct a reality in which being characterized as Woman, Animal, or Child marks moral degradation. By no coincidence, feminization, dehumanization, and infantilization are the very degradations used to make a man 'less of a man'. But this book is more than critique; it's also a guide to transformation especially for those grappling with what it means to be a man under patriarchy. Patriarchy's myths celebrate the identity Man, but these myths are no friend to most men. Promising strength and superiority, they instead fuel isolation, emotional repression, and relentless pressure to prove oneself while propping up systems that enrich the powerful few. Rather than deliver freedom and prosperity, these myths entrap and impoverish. Real Men on Top invites readers to see through them and, in so doing, to find new possibilities for living, relating, and becoming human. Sharp, daring, and deeply felt, Real Men on Top is a book for anyone who senses that something is deeply wrong with the way we live and wants to understand how we got here, and where we might begin the work of remaking reality. Robin Dembroff is an Associate Professor of Philosophy at Yale University Caleb Zakarin is CEO and Publisher of the New Books Network. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/gender-studies

In Real Men on Top: How Patriarchy Shapes Our Reality (Oxford University Press, 2026), Robin Dembroff shows us that we don't just live in a patriarchal world. We live in a world that patriarchy taught us to see. Patriarchy is not simply a system where men dominate women, Dembroff argues. It is a deeper reality-shaping force that legitimizes economic exploitation, political injustice, and social cruelty by dividing all of us into the rigid categories of Man, Woman, Animal, and Child. These categories are presented as natural truths, but Dembroff reveals them as man-made myths--ones that construct a reality in which being characterized as Woman, Animal, or Child marks moral degradation. By no coincidence, feminization, dehumanization, and infantilization are the very degradations used to make a man 'less of a man'. But this book is more than critique; it's also a guide to transformation especially for those grappling with what it means to be a man under patriarchy. Patriarchy's myths celebrate the identity Man, but these myths are no friend to most men. Promising strength and superiority, they instead fuel isolation, emotional repression, and relentless pressure to prove oneself while propping up systems that enrich the powerful few. Rather than deliver freedom and prosperity, these myths entrap and impoverish. Real Men on Top invites readers to see through them and, in so doing, to find new possibilities for living, relating, and becoming human. Sharp, daring, and deeply felt, Real Men on Top is a book for anyone who senses that something is deeply wrong with the way we live and wants to understand how we got here, and where we might begin the work of remaking reality. Robin Dembroff is an Associate Professor of Philosophy at Yale University Caleb Zakarin is CEO and Publisher of the New Books Network. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/critical-theory

Texas standout Brooks Bahr joins the program after a highly‑touted prep career and a church mission. Mitch Harper dives into how he’s feeling physically and mentally as he returns to basketball and looks to make an impact in his first season at BYU.

Molecular hydrogen improves your body's antioxidant defenses instead of directly lowering oxidative stress, helping you recover without blocking muscle adaptation Molecular hydrogen helps you maintain speed and power during repeated sprints, especially in the final, fatigue-heavy stages where performance normally declines Hydrogen supports your cellular energy systems by improving mitochondrial function, allowing your muscles to maintain power under stress Unlike traditional antioxidants, hydrogen targets only the most damaging molecules, preserving the signals your body relies on to build strength and endurance Using hydrogen in short, repeated doses, especially through hydrogen-rich water, strengthens your body's resilience and speeds recovery over time

Matt Williamson, former NFL scout and nationally renowned analyst, breaks down the Pittsburgh Steelers like no one else. Don't miss his insight, every Monday-Friday morning. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Promising oral treatment moves closer for Stargardt patients.

The final hour of Robby & Rexrode continues with Paul Kuharsky of paulkuharsky.com, who brings the latest on the Titans' mandatory mini-camp and the team's performance. Do the Titans have a strong WR core this year? It appears there are five promising WR's who can help contribute to the team. Should the Titans pursue Brendan Sorsby in the NFL supplementary draft?

Promising author, depressing life circumstances for our characters.

Knicks fan Rich basks in Jalen Brunson leading New York to its first NBA championship since 1973 ESPN's Mike Breen tells Rich what it was like to witness the Knicks-Spurs series courtside from the announcers' chair, what the NBA title win means for the city of New York, past players, and more. Rich and the guys react to Team USA's rout of Paraguay in their World Cup opener and what it could foretell about how far the USMNT's could advance in the knockout rounds. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Hour 3 -- Another addition of Danny's Double Dips. The guys also dive into the top young stars in Bay Area Sports, and are later joined by Rich Aurilia to break down the Giants epic comeback capped off by a Bryce Eldridge Grand Slam. See omnystudio.com/listener for privacy information.

President Donald Trump has changed a lot about American foreign policy – and to many, America itself. But a lot of the issues facing this country were around long before he became president. Ben Rhodes' new book, All We Say: The Battle for American Identity: A History in 15 Speeches, tells the story of this country through speeches by figures like Ben Franklin, Martin Luther King, and yes, Donald Trump. We spoke with Ben about what those speeches reveal about being American, and what Trump's actions in Iran can tell us about his presidency and our country.And in headlines, President Trump continues to whiplash in Iran talks, we have a new pick for the Director of National Intelligence, and Kash Patel prepares the FBI for the World Cup.Show Notes: Check out Ben's book – https://tinyurl.com/pxpr6t8c Call Congress – 202-224-3121 Subscribe to the What A Day Newsletter – https://tinyurl.com/y4y2e9jy What A Day – YouTube – https://www.youtube.com/@whatadaypodcast Follow us on Instagram – https://www.instagram.com/crookedmedia/ For a transcript of this episode, please visit crooked.com/whataday